Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Themis Bioscience
Pharma
Mostly quiet until now, Merck unveils a trio of COVID-19 deals
Merck & Co. inked a series of deals to advance three COVID-19 projects, trailing some of its large pharma peers into the industrywide research effort.
Eric Sagonowsky
May 26, 2020 10:53am
Themis’ chikungunya vaccine nabs fast FDA review
Feb 26, 2019 11:57am
Valneva scores quick FDA review for chikungunya vaccine
Jan 2, 2019 9:20am
Themis eyes phase 3 for chikungunya vaccine
Nov 7, 2018 10:10am
CEPI awards IDT Biologika up to $36M for MERS research
Aug 21, 2018 11:10am
Themis, Gardasil 9 and more—News of Note
Jun 13, 2018 9:30am
